H3-p-chloroamphetamine: cerebral levels and distribution

Area of Science:

• Pharmacokinetics
• Neuroscience
• Radiochemistry

Background:

• Understanding drug distribution and elimination in the brain is crucial for therapeutic development.
• Radioactive tracers are vital tools for studying drug metabolism and biodistribution.

Purpose of the Study:

• To investigate the whole-brain elimination kinetics of p-chlorocimetidine (p-CA) after intraventricular and intraperitoneal administration.
• To determine the distribution and subcellular localization of radioactivity in the brain over time.

Main Methods:

• Intraventricular and intraperitoneal injection of [3H]-p-CA in rats.
• Measurement of whole-brain radioactivity at multiple time points (0-14 days).
• Analysis of urinary excretion, peripheral distribution, brain region distribution, and subcellular localization of radioactivity.

Main Results:

• Brain radioactivity elimination followed a biphasic pattern with distinct half-lives for both administration routes.
• Radioactivity was detectable in all studied brain regions (cerebellum, neocortex, brainstem, telencephalon) up to 7 days post-injection.
• Four distinct radioactive peaks were identified in toluene extracts by 12 hours, indicating metabolite formation.
• A significant shift of radiolabel from supernatant to organelle-bound fractions occurred between 3 and 7 days.

Conclusions:

• p-CA exhibits prolonged retention and biphasic elimination from the brain.
• The drug and/or its metabolites distribute widely across brain regions and undergo subcellular sequestration.
• These findings provide insights into the pharmacokinetic profile and brain disposition of p-CA.